← All trials
NCT07257978
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jul 1, 2026
- Primary completion
- Oct 1, 2028
- Completion date
- Oct 1, 2028
- First posted
- Dec 2, 2025
- Last posted
- Dec 2, 2025
- Enrollment
- 40
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Fenix Innovation GroupLead sponsor
- Neurotech USACollaborator
Drugs studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.